(19)
(11) EP 3 749 683 A1

(12)

(43) Date of publication:
16.12.2020 Bulletin 2020/51

(21) Application number: 19751376.5

(22) Date of filing: 29.01.2019
(51) International Patent Classification (IPC): 
C07K 14/50(2006.01)
C12N 15/62(2006.01)
 C07K 19/00(2006.01)
A61P 3/10(2006.01)
(86) International application number:
PCT/CN2019/073686
(87) International publication number:
WO 2019/154189 (15.08.2019 Gazette 2019/33)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.02.2018 CN 201810129589

(71) Applicant: Sunshine Lake Pharma Co., Ltd.
Dongguan, Guangdong 523000 (CN)

(72) Inventors:
  • CHEN, Chao
    Dongguan, Guangdong 523871 (CN)
  • LIN, Shushan
    Dongguan, Guangdong 523871 (CN)
  • LI, Yu
    Dongguan, Guangdong 523871 (CN)
  • CHEN, Xiaofeng
    Dongguan, Guangdong 523871 (CN)
  • LI, Wenjia
    Dongguan, Guangdong 523871 (CN)
  • LIU, Liang
    Dongguan, Guangdong 523871 (CN)
  • FU, Zheng
    Dongguan, Guangdong 523871 (CN)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) FGF21 VARIANT, FUSION PROTEIN AND APPLICATION THEREOF